Der p2‑A20 DNA vaccine attenuates allergic inflammation in mice with allergic rhinitis

Hu,Wenhui; Ma,Li; Yang,Gui; Zeng,Xianhai; Liu,Jiangqi; Cheng,Baohui; Hu,Tianyong; Zhao,Hailiang; Liu,Zhiqiang

doi:10.3892/mmr.2019.10760

Der p2‑A20 DNA vaccine attenuates allergic inflammation in mice with allergic rhinitis

Authors:
- Wenhui Hu
- Li Ma
- Gui Yang
- Xianhai Zeng
- Jiangqi Liu
- Baohui Cheng
- Tianyong Hu
- Hailiang Zhao
- Zhiqiang Liu
View Affiliations

Affiliations: Department of Otolaryngology, Longgang ENT Hospital and Shenzhen Key Laboratory of ENT, Institute of ENT, Shenzhen, Guangdong 518172, P.R. China
Published online on: October 21, 2019 https://doi.org/10.3892/mmr.2019.10760
Pages: 4925-4932
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Allergic rhinitis (AR) is a common disease that requires more convenient, safe and effective antigen‑specific immunotherapies. The present study aimed to investigate the therapeutic effect of intranasal administration of a eukaryotic expression vector co‑expressing Der p2 and A20 protein (pVAX1‑Der p2‑A20) on mice with allergic rhinitis. The pVAX1‑Der p2‑A20 vaccine was prepared and encapsulated into poly(L‑lactide‑co‑glycolide) (PLGA) nanoparticles. An allergic rhinitis Balb/c mouse model was established through intraperitoneal sensitization with recombinant Der p2 and cholera toxin followed by intranasal challenge with recombinant Der p2. The treatment effect of the DNA vaccine on nasal allergic inflammation was evaluated, and serum IgE, sIgE, IgG and cytokine levels were determined by ELISA. The percentage of CD4+CD25+Foxp3+Tregs in the spleen was detected by flow cytometry. The DNA vaccine co‑expressing Der p2 and A20 was successfully constructed and encapsulated into PLGA nanoparticles. Der p2‑A20 DNA vaccine intranasal administration markedly ameliorated Der p2‑induced nasal allergic inflammation. The serum Der p2‑specific IgE, IL‑4 and IL‑13 expression levels were inhibited, while the Der p2‑specific IgG1, IgG2a and IFN‑γ expression levels in the serum and splenic CD4+CD25+Foxp3+Treg population were significantly increased after Der p2‑A20 DNA vaccine treatment. These results indicated that the Der p2‑A20 DNA vaccine alleviates nasal allergic inflammation and promotes splenic Treg population in mice with allergic rhinitis.

View Figures

View References

1	Small P, Keith PK and Kim H: Allergic rhinitis. Allergy Asthma Clin Immunol. 14:512018. View Article : Google Scholar : PubMed/NCBI
2	Zhang Y and Zhang L: Increasing prevalence of allergic rhinitis in china. Allergy Asthma Immunol Res. 11:156–169. 2019. View Article : Google Scholar : PubMed/NCBI
3	Hoffmann HJ, Valovirta E, Pfaar O, Moingeon P, Schmid JM, Skaarup SH, Cardell LO, Simonsen K, Larché M, Durham SR and Sørensen P: Novel approaches and perspectives in allergen immunotherapy. Allergy. 72:1022–1034. 2017. View Article : Google Scholar : PubMed/NCBI
4	Jutel M, Kosowska A and Smolinska S: Allergen immunotherapy: Past, present, and future. Allergy Asthma Immunol Res. 8:191–197. 2016. View Article : Google Scholar : PubMed/NCBI
5	Cui Y, Wang Q and Jia H: Consideration of methods for identifying mite allergens. Clin Transl Allergy. 8:142018. View Article : Google Scholar : PubMed/NCBI
6	Miller JD: The role of dust mites in allergy. Clin Rev Allergy Immunol. Jun 23–2018.(Epub ahead of print). PubMed/NCBI
7	Reihill JA, Malcomson B, Bertelsen A, Cheung S, Czerwiec A, Barsden R, Elborn JS, Dürkop H, Hirsch B, Ennis M, et al: Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells. Br J Pharmacol. 173:778–789. 2016. View Article : Google Scholar : PubMed/NCBI
8	Schuijs MJ, Willart MA, Vergote K, Gras D, Deswarte K, Ege MJ, Madeira FB, Beyaert R, van Loo G, Bracher F, et al: Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 349:1106–1110. 2015. View Article : Google Scholar : PubMed/NCBI
9	Tulic MK: Allergen-free immunotherapy using DNA vaccines in treatment of established allergic disease. Clin Exp Allergy. 42:3–4. 2012. View Article : Google Scholar : PubMed/NCBI
10	Weiss R, Hammerl P, Hartl A, Hochreiter R, Leitner WW, Scheiblhofer S and Thalhamer J: Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases. Curr Drug Targets Inflamm Allergy. 4:585–597. 2005. View Article : Google Scholar : PubMed/NCBI
11	Fonseca DM, Wowk PF, Paula MO, Campos LW, Gembre AF, Turato WM, Ramos SG, Dias-Baruffi M, Barboza R, Gomes E, et al: Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clin Exp Allergy. 42:131–143. 2012. View Article : Google Scholar : PubMed/NCBI
12	Hu T, Fan X, Ma L, Liu J, Chang Y, Yang P, Qiu S, Chen T, Yang L and Liu Z: TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression. Int J Mol Med. 40:1504–1510. 2017. View Article : Google Scholar : PubMed/NCBI
13	Wikstrom ME, Batanero E, Smith M, Thomas JA, von Garnier C, Holt PG and Stumbles PA: Influence of mucosal adjuvants on antigen pass age and CD4+ T cell activation during the primary response to airborne allergen. J Immunol. 177:913–924. 2006. View Article : Google Scholar : PubMed/NCBI
14	Ou J, Shi W, Xu Y and Tao Z: Intranasal immunization with DNA vaccine coexpressing Der p 1 and ubiquitin in an allergic rhinitis mouse model. Ann Allergy Asthma Immunol. 113:658–665.e651. 2014. View Article : Google Scholar : PubMed/NCBI
15	Chen Z, Tao ZZ, Zhou XH, Wu TT and Ye LF: Immunosuppressive effect of sinomenine in an allergic rhinitis mouse model. Exp Ther Med. 13:2405–2410. 2017. View Article : Google Scholar : PubMed/NCBI
16	Rothenberg ME, Saito H and Peebles RS Jr: Advances in mechanisms of allergic disease in 2016. J Allergy Clin Immunol. 140:1622–1631. 2017. View Article : Google Scholar : PubMed/NCBI
17	Gholami E, Oliveira F, Taheri T, Seyed N, Gharibzadeh S, Gholami N, Mizbani A, Zali F, Habibzadeh S, Bakhadj DO, et al: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica. PLoS Negl Trop Dis. 13:e00070672019. View Article : Google Scholar : PubMed/NCBI
18	Asbach B, Kibler KV, Kostler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, et al: Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost. J Virol. 93:e015292019.PubMed/NCBI
19	Dantzer JA and Wood RA: Next-generation approaches for the treatment of food allergy. Curr Allergy Asthma Rep. 19:52019. View Article : Google Scholar : PubMed/NCBI
20	Scheiblhofer S, Thalhamer J and Weiss R: DNA and mRNA vaccination against allergies. Pediatr Allergy Immunol. 29:679–688. 2018. View Article : Google Scholar : PubMed/NCBI
21	Su Y, Connolly M, Marketon A and Heiland T: CryJ-LAMP DNA vaccines for Japanese red cedar allergy induce robust Th1-Type immune responses in murine model. J Immunol Res. 2016:48578692016. View Article : Google Scholar : PubMed/NCBI
22	Pulsawat P, Pitakpolrat P, Prompetchara E, Kaewamatawong T, Techakriengkrai N, Sirivichayakul S, Buranapraditkun S, Hannaman D, Ruxrungtham K and Jacquet A: Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy. Immunol Lett. 151:23–30. 2013. View Article : Google Scholar : PubMed/NCBI
23	Das T, Chen Z, Hendriks RW and Kool M: A20/tumor necrosis factor α-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: Lessons from mouse models. Front Immunol. 9:1042018. View Article : Google Scholar : PubMed/NCBI
24	Li TL, Zhang SY, Du YC and Yang PC: Deficiency of ubiquitin A20 promotes antigen transport across airway epithelial cells via a transcellular pathway. Anal Biochem. 433:86–91. 2013. View Article : Google Scholar : PubMed/NCBI
25	Kelly C, Shields MD, Elborn JS and Schock BC: A20 regulation of nuclear factor-κB: Perspectives for inflammatory lung disease. Am J Respir Cell Mol Biol. 44:743–748. 2011. View Article : Google Scholar : PubMed/NCBI
26	Scott-Taylor TH, Axinia SC, Amin S and Pettengell R: Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy. Immun Inflamm Dis. 6:13–33. 2018. View Article : Google Scholar : PubMed/NCBI
27	Williams JW, Tjota MY and Sperling AI: The contribution of allergen-specific IgG to the development of th2-mediated airway inflammation. J Allergy (Cairo). 2012:2360752012.PubMed/NCBI
28	Wisniewski J, Agrawal R and Woodfolk JA: Mechanisms of tolerance induction in allergic disease: Integrating current and emerging concepts. Clin Exp Allergy. 43:164–176. 2013. View Article : Google Scholar : PubMed/NCBI
29	Maloy KJ and Powrie F: Regulatory T cells in the control of immune pathology. Nat Immunol. 2:816–822. 2001. View Article : Google Scholar : PubMed/NCBI
30	Baatjes AJ, Smith SG, Watson R, Howie K, Murphy D, Larché M, Denburg JA, Inman MD and O'Byrne PM: T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjects. Clin Exp Allergy. 45:1654–1662. 2015. View Article : Google Scholar : PubMed/NCBI
31	Lewkowich IP, Herman NS, Schleifer KW, Dance MP, Chen BL, Dienger KM, Sproles AA, Shah JS, Köhl J, Belkaid Y and Wills-Karp M: CD4⁺CD25⁺ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med. 202:1549–1561. 2005. View Article : Google Scholar : PubMed/NCBI
32	Chaisri U, Tungtrongchitr A, Indrawattana N, Meechan P, Phurttikul W, Tasaniyananda N, Saelim N, Chaicumpa W and Sookrung N: Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy. PLoS One. 12:e01886272017. View Article : Google Scholar : PubMed/NCBI